Neovacs, a biotech company, develops several therapeutic vaccines for the treatment of AIDS, cancer and auto-immune and allergic diseases. Founded by Daniel Zagury in 1993, Neovacs is backed by investors that include Bpifrance, Novartis Venture Fund, Debiopharm Innovation Fund, Alpha Blue Oceanâ¢, and Truffle Capital and is headquartered in Paris.
FOUNDED:
1993
INDUSTRY:
Biotechnology, Medical Device, Therapeutics
FOUNDERS:
Daniel Zagury
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
